http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012109687-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e49a3ca5ae333918732efd0b6fcd4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
filingDate 2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95535fde1ce268a7684ed11fd86c66a0
publicationDate 2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012109687-A1
titleOfInvention Medical System and Method for Providing Information for Glycemic Control
abstract A medical device and a method for configuring a process for determining a dose of insulin to be administered for glycemic control is provided, wherein the dose is stepwise adapted, comprising defining different dose adjustment profiles for stepwise adapting the dose, wherein each of the different dose adjustment profiles is based at least on a specific initial dose value, a specific time interval for increasing the dose, a specific dose increase step and a specific low blood glucose threshold value, storing the different dose adjustment profiles, selecting one of the stored different dose adjustment profiles based on specific requirements for stepwise adapting the dose, and personalising the selected dose adjustment profile by defining at least a specific target blood glucose value for a specific user.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022262470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10754926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10631574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018289975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020337381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10339272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017061943-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013138447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018077835-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015006187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11328800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11641882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11375936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018027878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015320116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013151270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11373759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016150828-A1
priorityDate 2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012015032-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765044

Total number of triples: 46.